Dr. Folashade M. Otegbeye, MD

  • Seattle, WA
  • Hematologist and oncologist
NPI1174837850PAC ID9638303118
Medicare services, 2024
51
Medicare patients, 2024
42
Part D claims, 2021
259
Publications
34
Clinical trials
2
Practice address
825 Eastlake Avenue East, Seattle, WA 98109
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Fred Hutchinson Cancer Center

Hospital · Seattle, Washington

Find Dr. Otegbeye's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Folashade M. Otegbeye is a hematologist and oncologist in Seattle, Washington

Dr. Otegbeye practices at Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center.

Dr. Otegbeye's NPI, 1174837850, was assigned on August 5, 2010. Dr. Otegbeye holds Washington license MD61176924.

NPI and contact details
Medicare PAC ID
9638303118
NPI enumeration date
August 5, 2010
NPI status
Active
Accepts Medicare assignment
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
47
Medical school graduation
2005

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Folashade M. Otegbeye practices at Fred Hutchinson Cancer Center in Seattle, Washington

Dr. Otegbeye's primary practice is Fred Hutchinson Cancer Center, at 825 Eastlake Avenue East, Seattle, WA 98109.

Source: Dmand AI Affiliation Data

Dr. Folashade M. Otegbeye is affiliated with 2 sites of care and 1 medical group

Dr. Otegbeye's primary practice is Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center. Dr. Otegbeye is also affiliated with UW Medical Center - Montlake. The medical group on file is UW Physicians.

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Folashade M. Otegbeye's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Otegbeye practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Fred Hutchinson Cancer CenterAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Otegbeye practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Fred Hutchinson Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Folashade M. Otegbeye is one of 348 hematologists and oncologists in Washington

Hematology and oncology is Dr. Otegbeye's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Otegbeye is licensed in Washington.

Specialties and state licenses

  • Hematology and oncology, WashingtonPrimaryLicense MD61176924 · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Otegbeye

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Folashade M. Otegbeye billed Medicare for 51 services in 2024

CMS data shows 51 Medicare services from Dr. Otegbeye across 1 procedure code in 2024, all of them office visits, for 42 Medicare patients. Medicare paid $6,482 for them. Every service was in an office.

Medicare services, 202451
Medicare patients42
Paid by Medicare$6,482
Procedure codes1

Dr. Otegbeye's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 1172024: 5156%

Dr. Otegbeye compared with the Washington median for hematologists and oncologists, 2024

  • Dr. Otegbeye
  • Washington median
Medicare services
51vs 58591% below
Medicare patients
42vs 18277% below
Part D claims
259vs 2838% below

Medians across 310 hematologists and oncologists in Washington with Dmand AI profiles that report each measure.

Dr. Otegbeye's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Otegbeye

Need commercial claims for Dr. Otegbeye?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Otegbeye and other hematologists and oncologists in Washington.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Folashade M. Otegbeye treated 42 Medicare patients in 2024, average age 70

CMS counts 42 Medicare patients who saw Dr. Otegbeye in 2024. The largest group is 65 to 74, with 30 patients. 75% of them have high cholesterol, and 74% have high blood pressure. Their average risk score is 3.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Otegbeye's median patient age at 64, with 40% women.

Medicare patients, 202442
Average age70
Average risk score3.12

Dr. Otegbeye's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Otegbeye's Medicare patients by sex, 2024

  • Women1740%
  • Men2560%

Chronic conditions among Dr. Otegbeye's Medicare patients, 2024

  1. High cholesterol75%
  2. High blood pressure74%
  3. Arthritis36%
  4. Anxiety33%
  5. Atrial fibrillation31%
  6. Ischemic heart disease31%
  7. Chronic kidney disease29%
  8. Cancer26%

Share of Medicare patients with each condition. A patient can have several.

Dr. Otegbeye's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 64

Patient panel by sex, all payers

  • Women40%
  • Men59%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Folashade M. Otegbeye wrote 259 Medicare Part D claims in 2021

In 2021, Dr. Otegbeye wrote 259 Medicare Part D claims. They cover 13 drugs, with $1,390,456 in total drug cost. In 2020, CMS named 420 claims across 17 drugs.

Part D claims, 2021259
Drugs named by CMS13
Total drug cost$1.4M

Dr. Otegbeye's most prescribed drugs by claims, 2021

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2020 to 2021

  • 2020
  • 2021
Claims for drugs CMS names
2020: 4202021: 25938%

Drugs named by CMS: 13 in 2021, 17 in 2020.

See all prescribing by Dr. Otegbeye

Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026

Dr. Folashade M. Otegbeye scored 94 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Otegbeye for performance year 2024, reported through an alternative payment model (APM). Dr. Otegbeye accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Otegbeye's MIPS scores, performance year 2024

  • 94of 100Final score
  • 74.6of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Otegbeye by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Folashade M. Otegbeye has 34 publications on record

Dmand AI links 34 papers to Dr. Otegbeye, published from 2017 to 2025. 2020 was the busiest year, with 6. The most frequent topics are Hematopoietic Stem Cell Transplantation, Killer Cells, Natural and Graft vs Host Disease. Dr. Otegbeye has published most often in Transplant Cell Ther. Dr. Otegbeye's most frequent co-authors are Marcos Jose Garcia De Lima, MD, Paolo F. Caimi, MD and Brenda W. Cooper, MD.

Papers34
Years published2017 to 2025

Dr. Otegbeye's papers by year, 2017 to 2025

Topics Dr. Otegbeye writes about most

  • Hematopoietic Stem Cell Transplantation
  • Killer Cells, Natural
  • Graft vs Host Disease
  • Leukemia, Myeloid, Acute
  • Transplantation, Homologous
  • Antineoplastic Combined Chemotherapy Protocols
  • Biopsy
  • Bone Marrow

Dr. Otegbeye's most frequent co-authors

Recent publications by Dr. Otegbeye

See all 34 publications and co-authors

See who Dr. Otegbeye researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Otegbeye works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Folashade M. Otegbeye has worked on 2 clinical trials

Dmand AI links Dr. Otegbeye to 2 clinical trials, 2 of them phase 1 studies. Conditions studied include Myeloproliferative Disorders, Sarcoma, Ewing and Myelodysplastic Syndromes.

Conditions in Dr. Otegbeye's trials

  • Myeloproliferative Disorders
  • Sarcoma, Ewing
  • Myelodysplastic Syndromes
  • Myosarcoma

Recent clinical trials with Dr. Otegbeye

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Folashade M. Otegbeye received $1,945 in industry payments from 2016 to 2023

CMS Open Payments shows 49 general payments to Dr. Otegbeye from 24 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Incyte Corporation paid the most, $420.

General payments to Dr. Otegbeye by program year, 2016 to 2023

Companies that paid Dr. Otegbeye the most, 2016 to 2023

Share is of all general payments to this clinician.

See all payments to Dr. Otegbeye

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Folashade M. Otegbeye's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Folashade M. Otegbeye

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Folashade M. Otegbeye's NPI number?

Dr. Folashade M. Otegbeye's NPI number is 1174837850. It was assigned on August 5, 2010, and it is active in the NPI Registry.

What kind of doctor is Dr. Folashade M. Otegbeye?

Dr. Folashade M. Otegbeye is a hematologist and oncologist in Seattle, Washington. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Folashade M. Otegbeye practice?

Dr. Otegbeye practices at 825 Eastlake Avenue East, Seattle, WA 98109. Dr. Otegbeye's primary practice is Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center.

What is Dr. Folashade M. Otegbeye's medical license number?

Dr. Otegbeye holds Washington license MD61176924.

Which hospitals is Dr. Folashade M. Otegbeye affiliated with?

Dr. Otegbeye practices at Fred Hutchinson Cancer Center in Seattle, Washington. Dr. Otegbeye is also affiliated with UW Medical Center - Montlake.

What medical group is Dr. Folashade M. Otegbeye part of?

Dr. Otegbeye is linked to UW Physicians.

Does Dr. Folashade M. Otegbeye accept Medicare?

Yes. CMS data shows Dr. Otegbeye billed Medicare for 51 services in 2024, and Dr. Otegbeye accepts Medicare assignment.

What is Dr. Folashade M. Otegbeye's MIPS score?

Dr. Otegbeye's MIPS final score for performance year 2024 is 94 out of 100, reported through an alternative payment model (APM).

How many Medicare patients does Dr. Folashade M. Otegbeye see?

CMS counts 42 Medicare patients who saw Dr. Otegbeye in 2024, with an average age of 70.

What services does Dr. Folashade M. Otegbeye bill to Medicare?

In 2024, Dr. Otegbeye's most billed Medicare services were office visit, established patient (99215).

Show 5 more questionsShow fewer questions

What drugs does Dr. Folashade M. Otegbeye prescribe most?

In 2021 Medicare Part D data, Dr. Otegbeye's most prescribed drugs by claims were Acyclovir, Hydroxyurea and Imbruvica.

Has Dr. Folashade M. Otegbeye received payments from drug or device companies?

CMS Open Payments shows $1,945 in general payments to Dr. Otegbeye from 24 companies from 2016 to 2023. The largest total came from Incyte Corporation.

How long has Dr. Folashade M. Otegbeye been practicing?

Dr. Otegbeye graduated from medical school in 2005, 21 years ago.

Does Dr. Folashade M. Otegbeye do research?

Dmand AI links 34 publications to Dr. Otegbeye, published from 2017 to 2025. Dr. Otegbeye has worked on 2 clinical trials.

Who does Dr. Folashade M. Otegbeye publish with?

Dr. Otegbeye's most frequent co-authors are Marcos Jose Garcia De Lima, MD (25 shared papers), Paolo F. Caimi, MD (18 shared papers) and Brenda W. Cooper, MD (16 shared papers).

Selling to hematology and oncology practices?

See hematologists and oncologists in Washington by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)